The management of coronavirus disease 2019 (COVID-19).

Jialin Liu, Siru Liu

Journal: Journal of medical virology 2020;92(9):1484-1490

PMID: 32369222

Abstract

In December 2019, a novel coronavirus causing severe acute respiratory disease occurred in Wuhan, China. It is an emerging infectious disease with widespread and rapid infectiousness. The World Health Organization declared the coronavirus outbreak to be a public health emergency of international concern on 31 January 2020. Severe COVID-19 patients should be managed and treated in a critical care unit. Performing a chest X-ray/CT can judge the severity of the disease. The management of COVID-19 patients includes epidemiological risk and patient isolation; treatment entails general supportive care, respiratory support, symptomatic treatment, nutritional support, psychological intervention, etc. The prognosis of the patients depends upon the severity of the disease, the patient's age, the underlying diseases of the patients, and the patient's overall medical condition. The management of COVID-19 should focus on early diagnosis, immediate isolation, general and optimized supportive care, and infection prevention and control.

© 2020 Wiley Periodicals LLC.

Address: Department of Otolaryngology, West China Hospital, Sichuan University, Sichuan, China.; Department of Medical Informatics, West China Medical School, Sichuan, China.; Department of Biomedical Informatics, University of Utah, Salt Lake, Utah.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.